Health‐related quality of life in adults with drug‐resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial
Epilepsia · 2023
DOI: 10.1111/epi.17585 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Epilepsia, 2023. Verfasst von Magnhild Kverneland und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Epilepsy, Member of the ERN EpiCARE, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Diet, High-Protein Low-Carbohydrate, Drug Resistant Epilepsy, Epilepsy, Diet, Ketogenic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Organization for Rare Disorders.
Abstract (Originalsprache)
Ketogenic diet, a high‐fat, low‐carbohydrate diet, is an established treatment for patients with severe epilepsy. We have previously reported a moderate reduction in seizure frequency after treatment with a modified Atkins diet. This study aimed to see whether dietary therapy impacts patients' health‐related quality of life (HRQOL). In a randomized controlled design, we compared the change in self‐reported HRQOL among adults with difficult‐to‐treat epilepsy after a 12‐week diet intervention. Thirty‐nine patients with drug‐resistant focal epilepsy (age = 16–65 years) were randomized to eat a modified Atkins diet with maximum 16 g of carbohydrate per day (diet group, n = 19) or to continue eating habitual diet (control group, n = 20). No changes to the other epilepsy treatments were allowed. Patient‐reported HRQOL was assessed with the Quality of Life in Epilepsy Inventory‐89 (QOLIE‐89). The diet group experienced a statistically significant improvement in mean total score of QOLIE‐89 of 10 points compared to controls ( p = .002). Moreover, although not statistically significant when using a cutoff of 50% seizure reduction, our data suggest an association between diet‐induced reduction in seizure frequency and improvement in HRQOL. The improvement in HRQOL was not associated with diet‐induced weight reduction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Center for Epilepsy, Member of the ERN EpiCARE, Oslo University Hospital, Oslo, Norway.
- Department of Nutrition, University of Oslo, Oslo, Norway.
- Department of Hematology, Oslo University Hospital, Oslo, Norway.
- Division of Clinical Neuroscience, Department of Research and Innovation, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
ORCID-Profile: Magnhild Kverneland
Förderung
- National Organization for Rare Disorders
Zitieren
APA
Kverneland, M., Nakken, K. O., Hofoss, D., Skogan, A. H., Iversen, P. O., Selmer, K. K., & Lossius, M. I. (2023). Health‐related quality of life in adults with drug‐resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial. Epilepsia. https://doi.org/10.1111/epi.17585
Vancouver
Kverneland M, Nakken KO, Hofoss D, Skogan AH, Iversen PO, Selmer KK, et al. Health‐related quality of life in adults with drug‐resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial. Epilepsia. 2023. doi:10.1111/epi.17585
BibTeX
@article{Kverneland2023,
author = {Kverneland, Magnhild and Nakken, Karl Otto and Hofoss, Dag and Skogan, Annette Holth and Iversen, Per Ole and Selmer, Kaja Kristine and Lossius, Morten Ingvar},
title = {Health‐related quality of life in adults with drug‐resistant focal epilepsy treated with modified Atkins diet in a randomized clinical trial},
journal = {Epilepsia},
year = {2023},
doi = {10.1111/epi.17585}
}
EUVIMED